Shuttle Pharma closes $600K convertible note offering; CEO invests $237.5K

Shuttle Pharmaceuticals Holdings, Inc.

Closed $600,000 of an up to $1.3 million senior secured convertible note and warrant offering.
CEO Anatoly Dritschilo invested $237,500 in the offering.
Notes carry 5% OID, 14.5% interest, 1-year term, convertible at 110% premium; prepayable at 107%.
Warrants for 45% of conversion shares, exercisable at 125% of prior day's closing price.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.